YHLO

2022-09-01

Summary:





Meet YHLO here at Medlab Asia 2022!
19-21 October 2022
Bangkok, Thailand
YHLO Booth: 5.A19
See you there!

Previous: Meet YHLO here at Medica 2022!

Next: YHLO innovative iFlash series showcased at the 2022 AACC Expo

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +